EUVIMEDEUVIMED entdecken
Crossref

Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line

Takuya Ono, Rei Noguchi, Julia Osaki, Taro Akiyama, Yuki Adachi, Naoki Kojima, Yu Toda, Suguru Fukushima, Yuki Yoshimatsu, Akihiko Yoshida, Akira Kawai, Tadashi Kondo

Human Cell · 2024

DOI: 10.1007/s13577-024-01030-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von Takuya Ono und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Hauptthemen laut MEDLINE: Dermatofibrosarcoma, Antineoplastic Agents, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatofibrosarcomaAntineoplastic AgentsSkin NeoplasmsHumansProto-Oncogene Proteins c-sisImatinib MesylateCell Line

Stichwörter der Autor:innen

Dermatofibrosarcoma protuberansFusion genePatient-derived cancer modelPatient-derived cell lineSarcoma

Substanzen

Proto-Oncogene Proteins c-sisImatinib MesylateAntineoplastic Agents

Autor:innen und Institutionen

  • Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Taro Akiyama, Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, 260-8670, Japan.
  • Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Department of Musculoskeletal Oncology and Rehabilitation Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Department of Patient-Derived Cancer Model, Tochigi Cancer Center, 4-9-13 Yohnan, Utsunomiya, Tochigi, 320-0834, Japan.

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Ono, T., Noguchi, R., Osaki, J., Akiyama, T., Adachi, Y., Kojima, N., Toda, Y., Fukushima, S., Yoshimatsu, Y., Yoshida, A., Kawai, A., & Kondo, T. (2024). Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line. Human Cell. https://doi.org/10.1007/s13577-024-01030-9

Vancouver

Ono T, Noguchi R, Osaki J, Akiyama T, Adachi Y, Kojima N, et al. Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line. Human Cell. 2024. doi:10.1007/s13577-024-01030-9

BibTeX
@article{Ono2024,
  author = {Ono, Takuya and Noguchi, Rei and Osaki, Julia and Akiyama, Taro and Adachi, Yuki and Kojima, Naoki and Toda, Yu and Fukushima, Suguru and Yoshimatsu, Yuki and Yoshida, Akihiko and Kawai, Akira and Kondo, Tadashi},
  title = {Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line},
  journal = {Human Cell},
  year = {2024},
  doi = {10.1007/s13577-024-01030-9}
}
Kostenlos starten →